• Magazine
    • Past Issues
    • Subscribe
    • Change Mailing Address
    • Surveys
    • Guidelines for Authors
    • Editorial Calendar
    • Editorial Deadlines
  • Practice
    • Business Tips
    • Chiropractic Schools
    • Clinical & Technique
    • eBooks
    • eCourses
    • Infographics
    • Quizzes
    • Wellness & Nutrition
    • Personal Growth
    • Podcast
  • Resource Centers
  • Products & Services
    • Buyer’s Guide
    • Products Directory
    • Submit a Product
    • Vendor Login
  • Datebook
    • Become an Events Poster
    • Post an Event
    • View Events
  • Jobs
    • Jobs
    • Post a Job
  • Advertise
    • Advertising Information
    • Media Kit
    • Contact Us
    • Upload Advertising

Your Online Chiropractic Community

Chiropractic Economics Your Online Chiropractic Community
Subscribe
  • Home
  • Current Issue
  • News
  • Webinars
  • Chiropractic Research
  • Students
  • Coronavirus (COVID-19)

Human study confirms anxiety reducing effects of AnxioFit-1

Chiropractic Economics May 10, 2012

May 10, 2012 — In a human clinical study published in the March issue of Phytotherapy Research, scientists found that AnxioFit-1 has a significant effect on relieving anxiety within only three days of use.

AnxioFit-1 is a highly specialized extract from a single form of echinacea (angustifolia), developed by the Hungarian Academy of Sciences. Past research has suggested that AnxioFit-1 attaches to cannabinoid receptors in the brain to elicit a sense of calm and relaxation, without drowsiness.

The study included 33 volunteers, 22 women, and 11 men with an average age of 41. All experienced mild anxiety. Anxiety was assessed using the State-Trait Anxiety Inventory (STAI), which is a clinically validated tool used to measure anxiety levels. Only individuals meeting the threshold for significant levels of anxiety were included in the study.

Subjects used AnxioFit-1 for one week, and anxiety was evaluated before, during, and after using the product. The daily dose (two 20 mg tablets per day) decreased STAI (both state and trait) scores within three days, an effect that remained stable for the duration of the treatment (seven days) and for the two weeks that followed treatment. There were no drop outs, demonstrating that the treatment was well tolerated. No serious adverse effects were recorded during the treatment period.

“Many people are surprised to find that there are unique compounds in echinacea that have a rapid effect on reducing anxiety and nervous tension,” states lead author Dr. Jozsef Haller. “AnxioFit-1 is a single spectrum of compounds found only in echinacea angustifolia. The extract is used at quite a low dose, which is 20 mg twice a day. This study confirms what we have seen in other AnxioFit-1 studies — that it is possible to greatly reduce anxiety without causing serious side effects and no issues with addiction or dependence.”

Source: EuroPharma Inc., eurapharmausa.com

Reference

1Haller J, Freund TF, Pelczer KG, Füredi J, Krecsak L, Zámbori J.The Anxiolytic Potential and Psychotropic Side Effects of an Echinacea Preparation in Laboratory Animals and Healthy Volunteers. Phytother Res. 2012 Mar 26. doi: 10.1002/ptr.4677.

Related Posts

  • TruGen3Results of the first cannabidiol (CBD) bioavailability clinical trial on human subjects released
  • Study shows BCM-95 curcumin more effective than placebo in treating major depressionStudy shows BCM-95 curcumin more effective than placebo in treating major depression
  • BCM-95 Curcumin used in prostate cancer and radiation therapy trialBCM-95 Curcumin used in prostate cancer and radiation therapy trial
  • New wellness book breaks through obstacles in healingNew wellness book breaks through obstacles in healing
  • Higher fiber intake tied to better lung functionHigher fiber intake tied to better lung function
  • Black men eat few fruits, vegetablesBlack men eat few fruits, vegetables

Filed Under: Industry News, News

Current Issue

Follow Us

  • Facebook
  • Twitter
  • Instagram
  • LinkedIn
  • YouTube logoYouTube logoYouTube

820 A1A N Highway W18,

Ponte Vedra Beach, FL 32082

Phone 904.285.6020

Fax 904.395.9118

CONTACT US »

Privacy Policy & Terms of Service

Copyright © 2021, All Rights Reserved

SUBSCRIBE TO THE MAGAZINE

Get Chiropractic Economics magazine
delivered to your home or office. Just
fill out our form to request your FREE
subscription for 20 issues a year,
including two annual Buyers Guides.

SUBSCRIBE NOW »

Latest Chiropractic News

  • Colorado allows chiropractors to give COVID-19 vaccine shots
  • American Chiropractic Association lauds U.S. Congress passing fair competition health legislation
    The American Chiropractic Association (ACA) lauded the U.S. Congress for passing legislation that will promote fair competition in health...
  • Logan University debuts new health center
    Logan University logo
x